151 related articles for article (PubMed ID: 23181052)
1. Normal ATXN3 Allele but Not CHIP Polymorphisms Modulates Age at Onset in Machado-Joseph Disease.
França MC; Emmel VE; D'Abreu A; Maurer-Morelli CV; Secolin R; Bonadia LC; da Silva MS; Nucci A; Jardim LB; Saraiva-Pereira ML; Marques W; Paulson H; Lopes-Cendes I
Front Neurol; 2012; 3():164. PubMed ID: 23181052
[TBL] [Abstract][Full Text] [Related]
2. Variants in Genes of Calpain System as Modifiers of Spinocerebellar Ataxia Type 3 Phenotype.
Martins AC; Rieck M; Leotti VB; Saraiva-Pereira ML; Jardim LB
J Mol Neurosci; 2021 Sep; 71(9):1906-1913. PubMed ID: 34191270
[TBL] [Abstract][Full Text] [Related]
3. The role of apolipoprotein E as a risk factor for an earlier age at onset for Machado-Joseph disease is doubtful.
Zhou Q; Ni W; Dong Y; Wang N; Gan SR; Wu ZY
PLoS One; 2014; 9(11):e111356. PubMed ID: 25369462
[TBL] [Abstract][Full Text] [Related]
4. APOE ε2 allele may decrease the age at onset in patients with spinocerebellar ataxia type 3 or Machado-Joseph disease from the Chinese Han population.
Peng H; Wang C; Chen Z; Sun Z; Jiao B; Li K; Huang F; Hou X; Wang J; Shen L; Xia K; Tang B; Jiang H
Neurobiol Aging; 2014 Sep; 35(9):2179.e15-8. PubMed ID: 24746364
[TBL] [Abstract][Full Text] [Related]
5. Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Mergener R; Furtado GV; de Mattos EP; Leotti VB; Jardim LB; Saraiva-Pereira ML
Neuromolecular Med; 2020 Mar; 22(1):133-138. PubMed ID: 31587151
[TBL] [Abstract][Full Text] [Related]
6. Two novel SNPs in ATXN3 3' UTR may decrease age at onset of SCA3/MJD in Chinese patients.
Long Z; Chen Z; Wang C; Huang F; Peng H; Hou X; Ding D; Ye W; Wang J; Pan Q; Li J; Xia K; Tang B; Ashizawa T; Jiang H
PLoS One; 2015; 10(2):e0117488. PubMed ID: 25689313
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variation in ATXN3 (Ataxin-3) 3'UTR: Insights into the Downstream Regulatory Elements of the Causative Gene of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3.
Melo ARV; Raposo M; Ventura M; Martins S; Pavão S; Alonso I; Bettencourt C; Lima M
Cerebellum; 2023 Feb; 22(1):37-45. PubMed ID: 35034258
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study identifies genetic factors that modify age at onset in Machado-Joseph disease.
Akçimen F; Martins S; Liao C; Bourassa CV; Catoire H; Nicholson GA; Riess O; Raposo M; França MC; Vasconcelos J; Lima M; Lopes-Cendes I; Saraiva-Pereira ML; Jardim LB; Sequeiros J; Dion PA; Rouleau GA
Aging (Albany NY); 2020 Mar; 12(6):4742-4756. PubMed ID: 32205469
[TBL] [Abstract][Full Text] [Related]
9. Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis.
de Mattos EP; Kolbe Musskopf M; Bielefeldt Leotti V; Saraiva-Pereira ML; Jardim LB
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):203-210. PubMed ID: 30337442
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in DNA methylation-related genes are linked to the phenotype of Machado-Joseph disease.
Ding D; Wang C; Chen Z; Peng H; Li K; Zhou X; Peng Y; Wang P; Hou X; Li T; Qiu R; Xia K; Sequeiros J; Ashizawa T; Tang B; Jiang H
Neurobiol Aging; 2019 Mar; 75():225.e1-225.e8. PubMed ID: 30554804
[TBL] [Abstract][Full Text] [Related]
11. CAG Repeat Size Influences the Progression Rate of Spinocerebellar Ataxia Type 3.
Leotti VB; de Vries JJ; Oliveira CM; de Mattos EP; Te Meerman GJ; Brunt ER; Kampinga HH; Jardim LB; Verbeek DS
Ann Neurol; 2021 Jan; 89(1):66-73. PubMed ID: 32978817
[TBL] [Abstract][Full Text] [Related]
12. Age at onset prediction in spinocerebellar ataxia type 3 changes according to population of origin.
de Mattos EP; Leotti VB; Soong BW; Raposo M; Lima M; Vasconcelos J; Fussiger H; Souza GN; Kersting N; Furtado GV; Saute JAM; Camey SA; Saraiva-Pereira ML; Jardim LB
Eur J Neurol; 2019 Jan; 26(1):113-120. PubMed ID: 30125433
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA haplogroups and age at onset of Machado-Joseph disease/spinocerebellar ataxia type 3: a study in patients from multiple populations.
Ramos A; Planchat M; Vieira Melo AR; Raposo M; Shamim U; Suroliya V; Srivastava AK; Faruq M; Morino H; Ohsawa R; Kawakami H; Bannach Jardim L; Saraiva-Pereira ML; Vasconcelos J; Santos C; Lima M
Eur J Neurol; 2019 Mar; 26(3):506-512. PubMed ID: 30414314
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological, clinical, and molecular characterization of Cuban families with spinocerebellar ataxia type 3/Machado-Joseph disease.
González-Zaldívar Y; Vázquez-Mojena Y; Laffita-Mesa JM; Almaguer-Mederos LE; Rodríguez-Labrada R; Sánchez-Cruz G; Aguilera-Rodríguez R; Cruz-Mariño T; Canales-Ochoa N; MacLeod P; Velázquez-Pérez L
Cerebellum Ataxias; 2015; 2():1. PubMed ID: 26331044
[TBL] [Abstract][Full Text] [Related]
15. Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report.
Bettencourt C; Santos C; Coutinho P; Rizzu P; Vasconcelos J; Kay T; Cymbron T; Raposo M; Heutink P; Lima M
BMC Neurol; 2011 Oct; 11():131. PubMed ID: 22023810
[TBL] [Abstract][Full Text] [Related]
16. Modifiers of (CAG)(n) instability in Machado-Joseph disease (MJD/SCA3) transmissions: an association study with DNA replication, repair and recombination genes.
Martins S; Pearson CE; Coutinho P; Provost S; Amorim A; Dubé MP; Sequeiros J; Rouleau GA
Hum Genet; 2014 Oct; 133(10):1311-8. PubMed ID: 25026993
[TBL] [Abstract][Full Text] [Related]
17. Machado-Joseph disease/SCA3 and myotonic dystrophy type 1 in a single patient.
Miura S; Ohyagi Y; Miike T; Noda K; Motomura K; Ayabe M; Aizawa H; Taniwaki T
Clin Neurol Neurosurg; 2009 Dec; 111(10):791-4. PubMed ID: 19713033
[TBL] [Abstract][Full Text] [Related]
18. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
[TBL] [Abstract][Full Text] [Related]
19. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD.
Wang C; Peng H; Li J; Ding D; Chen Z; Long Z; Peng Y; Zhou X; Ye W; Li K; Xu Q; Ai S; Song C; Weng L; Qiu R; Xia K; Tang B; Jiang H
Neurobiol Aging; 2017 May; 53():192.e5-192.e10. PubMed ID: 28094059
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.
Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS
PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
